FBInvestor
Stocks / Merrimack Pharmaceuticals In
Institutional Ownership

Merrimack Pharmaceuticals In

CUSIP 590328209COMMACKEURQ1 2026

No short-interest data on record yet

FINRA publishes consolidated short interest twice a month. Coverage expands as the bi-monthly feed runs.